Attention-Deficit Hyperactivity Disorder: by Chris Golner
Attention-Deficit Hyperactivity Disorder: by Chris Golner
Disorder
By
Chris Golner
Outcome
History of ADHD
Mid-1800s: Minimal Brain Damage
Mid 1900s: Minimal Brain Dysfunction
1960s: Hyperkinesia
1980: Attention-Deficit Disorder
With or Without Hyperactivity
1987: Attention Deficit Hyperactivity Disorder
1994-present: ADHD
Primarily Inattentive
Primarily Hyperactive
Combined Type
Diagnosing ADHD: DSM-IV
Lacks attention to detail;
makes careless mistakes
Inattentiveness: has difficulty sustaining
attention
doesn’t seem to listen
Has a minimum of 6 fails to follow through/fails
symptoms regularly for to finish projects
the past six months. has difficulty organizing
tasks
Symptoms are present at avoids tasks requiring
abnormal levels for stage mental effort
of development
often loses items necessary
for completing a task
easily distracted
is forgetful in daily activities
Diagnosing ADHD: DSM-IV
Fidgets or squirms
Hyperactivity/ excessively
leaves seat when
Impulsivity: inappropriate
runs about/climbs
extensively when
Has a minimum of 6 inappropriate
symptoms regularly for the has difficulty playing
past six months. quietly
often “on the go” or “driven
Symptoms are present at by a motor”
abnormal levels for stage of talks excessively
development blurts out answers before
question is finished
cannot await turn
interrupts or intrudes on
others
Diagnosing ADHD: DSM-IV
Symptoms causing impairment
Additional present before age 7
Criteria: Impairment from symptoms
occurs in two or more settings
Clear evidence of significant
impairment (social, academic,
etc.)
Symptoms not better accounted
for by another mental disorder
Problems of Diagnosis
Subjectivity of Criteria
Inconsistent evaluations--presence of
symptoms usually given by teacher or parent
Study by Szatmari et al (1989) showed that the
number of diagnosed cases of ADHD
decreased 80% when observations of parent,
teacher and physician were used rather than
just one source
Symptoms in females more subtle---leads to
underdiagnosis
ADHD and the Brain
Diminished arousal of
the Nervous System
Decreased blood flow
to prefrontal cortex
and pathways
connecting to limbic
system (caudate
nucleus and striatum)
PET scan shows
Comparison of normal brain (left) and brain
decreased glucose of ADHD patient.
metabolism
throughout brain
ADHD and the Brain II
Similarities of ADHD symptoms to those from
injuries and lesions of frontal lobe and
prefrontal cortex
MRIs of ADHD patients show:
Smaller anterior right frontal lobe
abnormal development in the frontal and striatal regions
Significantly smaller splenium of corpus callosum
decreased communication and processing of
information between hemispheres
Smaller caudate nucleus
What causes ADHD?
Underlying cause of these differences is still
unknown; there is much conflicting data between
studies
Strong evidence of genetic component
Predominant theory: Catecholamine
neurotransmitter dysfunction or imbalance
decreased dopamine and/or norepinephrine
uptake in brain
theory supported by positive response to
stimulant treatment
Recent study indicates possible lack of serotonin
as a factor in mice
Dopamine in the Brain
Scientific American
Http//www.sciam.com/1998/0998issue/0998barkely.html#link1
Genetic Linkages to ADHD
Twin studies by Stevenson, Levy et al, and
Sherman et al indicate an average heritability
factor of .80
Biederman et al reported a 57% risk to offspring if
one parent has ADHD.
Dopamine genes
DA type 2 gene
DA transporter gene (DAT1)
Dopamine receptor (DRD4, “repeater gene”) is
over-represented in ADHD patients
DRD4
DRD4 is most likely contributor
DRD4 affects the post-synaptic sensitivity in
the prefrontal and frontal cortex
This region of cortex affects executive
functions and attention
Executive functions include working
memory, internalization of speech, emotions,
motivation, and learning of behavior
Treatment
Counseling of individual and family
Stimulants
Tricyclic antidepressants
Bupropion
Clonidine
Stimulants
Exact mechanism unknown
Raise activity level of the CNS by decreasing
fluctuations of activity or lowering threshold
needed for arousal
Similar in structure to NE and DA, and may
mimic their actions
At least 75% have positive response with single
dose
95% respond well to stimulant treatment
Include methylphenidate, dextroamphetamine
and pemoline
Methylphenidate
Is a piperidine Taken orally, 2-3 times
derivative commonly a day as needed
known as Ritalin® Behavioral effects start
Is believed to act as within 1/2 hour to hour
dopamine agonist in after ingestion, peaking
synaptic cleft at 1 and 3 hours
Stimulates frontal- Also comes in
striatal regions Sustained-Release
Dosage (5-20 mg) must form, whose effects last
be adjusted to each approximately twice as
patient long.
Effects of MPH
Elevates mood
Raises arousal of CNS and cerebral blood
flow
Increases productivity
Improves social interactions
Increases heart rate and blood pressure
Has little or no abuse potential
Side Effects
Common: Mild:
decreased appetite anxiety/ depression
insomnia irritability
behavioral Rare:
rebound tics (Tourette’s
head and stomach Syndrome)
aches overfocussing
liver problems or
Also thought to cause rash (Pemoline
temporary height and only)
weight suppression
Outcome
ADHD can persist into adulthood, but usually
symptoms gradually diminish
When it persists into adulthood, it usually requires
ongoing treatment and counseling
most will develop another disorder (especially
learning disability, ODD, depression, and/or
conduct disorder)
Without treatment:
antisocial and deviant behavior
increased rates of divorce, moving violations,
incarceration, and institutionalization
References
Barkley, R. Attention-Deficit Hyperactivity Disorder, 2 nd Ed. New York: Guilford Press. 1998.
628 pp.
Shaywitz, B. and Shaywitz, S. Attention Deficit Disorder Comes of Age: Toward the 21st Century.
Austin, TX: Hammill Foundation. 1992. 366 pp.
Rie, H.E. and Rie, E.D., Eds. Handbook of Minimal Brain Dysfunctions: A Critical View. New
York: John Wiley & Sons. 1980. 744 pp.
Faigel, H. Attention Deficit Disorder: A Review. J. of Adolesc. Health, Mar 1995 Vol. 16: 174-84.
Cantwell, D.P. Attention Deficit Disorder: A Review of the Past Ten Years. J. of the Am. Acad. Of
Child Adolesc. Psychiatry. 1996, Vol 35: 978-87.
Seideman, L., Biederman, J., and Faraone, S.V. A Pilot Study of Neuropsychological Function in
Girls with ADHD. J. of Am. Acad. of Child Adolesc. Psychiatry, 1997. Vol. 36: 366-73.
Seideman, L., Biederman, J., and Faraone, S.V. A Pilot Study of Neuropsychological Function in
Girls with ADHD. J. of Am. Acad. of Child Adolesc. Psychiatry, 1997. Vol. 36: 366-73.
References
Levy, F., Hay D.A., McStephen, M., Wood, C., and Waldman, I. Attention-Deficit Hyperactivity
Disorder: A Category or Continuum? Genetic Analysis of a Large Scale Twin Study. J. of Am.
Acad. Of Child Adolesc. Psychiatry, 1997, Vol 36: 737-44.
Sherman, D.K., Iacono, W.G., McGue, M.K. Attention-Deficit Hyperactivity Disorder Dimensions:
A Twin Study of Inattention and Impulsivity-Hyperactivity. J. of Am. Acad. Of Child Adolesc.
Psychiatry, 1997, Vol 36: 737-44.
Marx, J. How Stimulant drugs May Clam Hyperactivity. Science, 1999, Vol. 283: 306-08.
http://www.sciencemag.org/cgi/content/full/283/5400/306?
maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=Attention+Deficit+Disorder
&searchid=QID_NOT_SET&FIRSTINDEX=